GlassScriptPhysician profile
Meagan Slate
NPI 1386091874
$2,730.29
in general payments reported to CMS, 2019-2025
25 companies · $1,016 in 2025
The $1,016 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $80.00 · 2021: $172 · 2022: $35.70 · 2023: $433 · 2024: $659 · 2025: $1,016.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,108.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $497.06 | 2024-2025 | Harmonic, Vistaseal, Megadyne |
| Asensus Surgical, INC. | $333.95 | 2019 | |
| Davol INC. | $253.42 | 2025 | Arista |
| Astellas Pharma US INC | $196.37 | 2023-2025 | Veozah |
| Myriad Women'S Health, INC. | $173.17 | 2023 | Myrisk |
| Coopersurgical, INC. | $164.14 | 2023-2024 | Wallach Cryosurgical Equipment, Advincula Delineator Uterine Manipulator, Paragard T 380a |
| Exeltis, USA INC. | $125.56 | 2023-2025 | Slynd |
| Millicent US INC | $124.06 | 2023-2025 | Femring, Intrarosa, Femlyv |
| Renovia INC | $86.81 | 2021 | |
| Therapeuticsmd, INC. | $85.91 | 2020-2021 | |
| Abbvie INC. | $80.34 | 2021-2025 | Orilissa, Lo Loestrin Fe |
| Avanos Medical | $78.25 | 2025 | On-Q Pump and Accessories |
| Pfizer INC. | $67.97 | 2023-2024 | |
| Mayne Pharma Commercial LLC | $65.38 | 2025 | |
| Merck Sharp & Dohme LLC | $55.35 | 2024-2025 | Gardasil 9, Gardasil |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $53.17 | 2025 | Zepbound |
| Aspira Women'S Health INC | $47.20 | 2023-2024 | Ova1 |
| Evofem Biosciences, INC. | $44.59 | 2021 | |
| Hologic Sales and Service, LLC | $43.81 | 2024-2025 | Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $39.00 | 2020-2022 | |
| Intuitive Surgical, INC. | $34.73 | 2023 | Da Vinci Surgical System |
| Exact Sciences Corporation | $31.34 | 2024 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $25.04 | 2023 | Myfembree |
| Becton, Dickinson and Company | $14.30 | 2022 | |
| Channel Medsystems, INC. | $9.37 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meagan Slate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.